城建發展(600266.SH)擬註冊發行不超50億元債權投資計劃
格隆匯 12 月 4日丨城建發展(600266.SH)公佈,公司召開第七屆董事會第四十六次會議,審議通過了關於公司擬註冊發行不超過50億元債權投資計劃的議案。
同意公司以新華資產管理股份有限公司(“新華資產”)作為受託人,在中國銀行保險監督管理委員會指定的註冊機構發起設立“新華-城建發展基礎設施債權投資計劃(一期、二期)”(正式名稱以產品註冊通知書為準,“債權投資計劃”)。
該債權投資計劃分二期註冊,總規模不超過人民幣50億元,期限為5+3N年(初始期限5年及每次屆滿3年公司有到期贖回權)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.